According to the World Health Organisation (WHO), iron deficiency affects upto one-third of the world's population 1,2 , and is particularly common in elderly individuals and those with certain chronic diseases 1 such as chronic kidney disease 3,4 , congestive heart failure 5 or inflammatory bowel disease 2,6 .
Iron deficiency is specifically a common comorbidity for patients with chronic diseases. It significantly impacts Quality of Life (QoL) 7 and can influence clinical outcomes, making it a concern for both patients and physicians.
Prof. Maria Cappellini, University of Milan, Italy, says: "Iron deficiency is very common but often overlooked, especially in people with chronic conditions. Iron deficiency is a health-related condition in which iron availability is insufficient to meet body needs and therefore its timely detection and treatment is important, because iron is essential to the functioning of multiple organs."
Vifor Pharma supports various activities around the world to highlight the impact of iron deficiency and raise awareness, for example:
Data show that nearly one third of the population is not aware of iron deficiency and iron deficiency anaemia. Even among those people who are aware of iron deficiency, one third cannot recognise its symptoms 8 . In light of the 2 nd Global Iron Deficiency Day on November 26, 2016, Vifor Pharma reaffirms its commitment to further educate people and healthcare professionals to recognise the symptoms of the disease.
Link to website: http://www.irondeficiency.com
For further information, please contact:
Beatrix Benz, Head of Global Communications & Public Affairs
Tel.: +41 58 851 80 16
, a company of the Galenica Group, is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as over-the-counter (OTC) products. Vifor Pharma, headquartered in Zurich, Switzerland, has an increasingly global presence and a broad network of affiliates and partners around the world.
For more information about Vifor Pharma and its parent company Galenica, please visit www.viforpharma.com and www.galenica.com .
1. WHO. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. 2009 Available from:
/GlobalHealthRisks_report_Front.pdf [Accessed September 2016]
2. Peyrin-Biroulet L, et al. Am J Clin Nutr. 2015;102:1585-94
3. Clark SF Nutr Clin Pract 2008; 23; 128 DOI: 10.1177/0884533608314536
4. Post JB Int Urol Nephrol. 2006; 38:719-723
5. Okonko DO J Am Coll Cardiology 2011; Vol. 58, No. 12, 2011
6. Ponikowski P, et al. Eur Heart J 2016;37:2129-200
7. Stein J et al.,. Anemia and iron deficiency in gastrointestinal and liver conditions. World J Gastroenterol 2016 Sep21; 22(35): 7908-7925
8. Caramelo L, Mezzacasa A and Kassebaum NJ. Iron Deficiency. Understanding perceptions of sufferers and the general public. EHA 21st Annual Congress, 9-12 June 2016, Copenhagen, Denmark
9. Caramelo L, Mezzacasa A and Mansour D. Iron Deficiency. Impact of iron deficiency on QoL and work capacity. EHA 21st Annual Congress, 9-12 June 2016, Copenhagen, DenmarkPress Release (PDF)
Last updated on: 25/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.